Filing Flows › Comparisons › PTCT vs INDV
PTC Therapeutics vs Indivior Pharmaceuticals: PTCT and INDV compared
PTC Therapeutics is the larger company: $358M of revenue in its latest quarter (Q3 2026) against $356M for Indivior Pharmaceuticals (Q3 2026). PTC Therapeutics is growing faster (+70% against +13% a year earlier). Indivior Pharmaceuticals is more profitable, with an operating margin of 50.6% against 7.0%.
Where the money goes: PTCT and INDV
PTC Therapeutics (PTCT) · Q3 2026
PTC Therapeutics, Q3 2026: revenue $358M (+70% year over year), operating margin 7.0%, net loss $51.7M, operating cash flow −$25.3M. The chart follows the revenue to costs, profit and cash.
Indivior Pharmaceuticals (INDV) · Q3 2026
Indivior Pharmaceuticals, Q3 2026: revenue $356M (+13% year over year), operating margin 50.6%, net earnings $137M, operating cash flow $97.0M. The chart follows the revenue to costs, profit and cash.
| PTC Therapeutics (PTCT) | Indivior Pharmaceuticals (INDV) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $358M | $356M |
| Revenue growth, Y/Y | +70% | +13% |
| Gross margin | — | 85.7% |
| Operating margin | 7.0% | 50.6% |
| Net earnings | −$51.7M | $137M |
| Net margin | -14.4% | 38.5% |
| Operating cash flow | −$25.3M | $97.0M |
| Free cash flow | — | $83.0M |
| Market value | $5.5B | $4.4B |
| P/E | — | 10.1× |
| Analysts’ mean target | $100.47 | $49.50 |
Where the revenue comes from
PTC Therapeutics
- Net product revenue: $276M (77%)
- Royalty revenue: $81.7M (23%)
- Collaboration and license revenue: $229K (0%)
Questions
Which is bigger, PTC Therapeutics or Indivior Pharmaceuticals?
PTC Therapeutics is the larger company: $358M of revenue in its latest quarter (Q3 2026) against $356M for Indivior Pharmaceuticals (Q3 2026).
Is PTC Therapeutics or Indivior Pharmaceuticals growing faster?
PTC Therapeutics is growing faster (+70% against +13% a year earlier).
Which is more profitable, PTC Therapeutics or Indivior Pharmaceuticals?
Indivior Pharmaceuticals is more profitable, with an operating margin of 50.6% against 7.0%.
More: PTC Therapeutics earnings · how PTC Therapeutics makes money · Indivior Pharmaceuticals earnings · how Indivior Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 29, 2026; 10-Q filed Oct 29, 2026). Fiscal quarters can end on different dates. Not investment advice.